cimadronate has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
| Studies (cimadronate) | Trials (cimadronate) | Recent Studies (post-2010) (cimadronate) | Studies (n-formylmethionine leucyl-phenylalanine) | Trials (n-formylmethionine leucyl-phenylalanine) | Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine) |
|---|---|---|---|---|---|
| 105 | 3 | 4 | 6,716 | 53 | 356 |
| Protein | Taxonomy | cimadronate (IC50) | n-formylmethionine leucyl-phenylalanine (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funaba, Y; Kawabe, N; Nakadate-Matsushita, T; Tanahashi, M; Tateishi, A | 1 |
1 other study(ies) available for cimadronate and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
TRK-530 inhibits accumulation of superoxide anions derived from human polymorphonuclear leukocytes and bone resorption induced by activated osteoclasts.
Topics: Animals; Animals, Suckling; Antioxidants; Bone Resorption; Calcitriol; Calcium Channel Blockers; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Hindlimb; Humans; Mice; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Osteoclasts; Risedronic Acid; Superoxides | 1998 |